Time course of endothelin-1 plasma level in patients with acute coronary syndromes

Cardiology

Volumn 91, Issue 2, 1999, Pages 114-118

  Vojáček, Jan ^a   Kolář, Jiří ^a   Lisý, Ondřej ^a   Hraboš, Vladimír ^a   Šimek, Stanislav ^a   Jindra Jr , Antonín ^a   Jáchymová, Marie ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acute coronary syndromes; Angina pectoris, unstable; Endothelin 1; Myocardial infarction

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENDOTHELIN 1; HEPARIN; NITRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DISEASE COURSE; FEMALE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PATIENT REFERRAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0344931787     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006890     Document Type: Article

References (43)

1. Lüscher TF: Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation 1990; 82:188-195.
2. Lüscher TF, Boulanger CM, Dohi Y, Yang Z: Endothelium-derived contracting factors. Hypertension 1992;19:117-130.
3. Lüscher TF, Richard V, Tschudi M, Yang Z, Boulanger C: Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol 1990;15:519-527.
4. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ: Plasma endothelin in chronic heart failure. Circulation 1992;85:1374-1379.
5. Cody RJ: The potential role of endothelin as a vasoconstrictor substance in congestive heart failure. Eur Heart J 1992;13:1573-1578.
6. Clavell A, Stingo A, Margulies K, Lerman A, Underwood D, Burnett JC Jr: Physiological significance of endothelin. Its role in congestive heart failure. Circulation 1993;87(suppl V):V-45-V-50.
7. Goerre S, Wenk M, Bartsch P, Lüscher TF, Niroomand F, Hohenhaus E, Oelz O, Reinhart WH: Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 1995;91:359-364.
8. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ: Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732-1739.
9. Cacoub P, Dorent R, Maistre G, Nataf P, Carayon A, Piette JC, Godeau P, Cabrol C, Gandjbakhch I: Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol 1993;71:448-450.
10. Vincent JA, Ross RD, Kassab J, Hsu JM, Pinsky WW: Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow. Am J Cardiol 1993;71: 1204-1207.
11. Yamamoto K, Ikeda U, Mito H, Fujikawa H, Sekiguchi H, Shimada K: Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation 1994;89:2093-2098.
12. Arendt RM, Wilbert-Lampen U, Heucke L, Schmoeckel M, Sühler K, Richter WO: Increased endothelin plasma concentrations in patients with coronary artery disease or hyperlipoproteinemia without coronary events. Res Exp Med 1993;193:225-230.
13. Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Shin WS, Yanagisawa M, Masaki T, Sugimoto T: Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 1991;83:476-483.
14. Stewart DJ, Kubac G, Costello KB, Cernacek P: Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 1991;18:38-43.
15. Wieczorek I, Haynes WG, Webb DJ, Ludlam CA, Fox KAA: Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: Relation to cardiovascular outcome. Br Heart J 1994;72:436-441.
16. Wieczorek I, Fox K, Ludlam C, Haynes W, Webb D: Refractory unstable angina is associated with persistently elevated plasma levels of endothelin. J Am Coll Cardiol 1993;21:271A.
17. Qiu S, Theroux P, Marcil M, Solymoss BC: Plasma endothelin-1 levels in stable and unstable angina. Cardiology 1993;82:12-19.
18. Tamirisa P, Frishman WH, Kumar A: Endothelin and endothelin antagonism: Roles in cardiovascular health and disease. Am Heart J 1995;130:601-610.
19. Velasco CE, Atkinson JB, Kondo T, Virmani R, Inagami T, Forman MB: Enhanced local endothelin release contributes to no-reflow phenomenon in the canine model (abstract). J Am Coll Cardiol 1991;17:305A.
20. Velasco CE, Turner M, Inagami T, Atkinson JB, Virmani R, Jackson EK, Murray JJ, Forman MB: Reperfusion enhances the local release of endothelin after regional myocardial ischemia. Am Heart J 1994;128:441-451.
21. Tsuji J, Sawamura A, Watanabe H, Takihara K, Park SE, Azuma J: Plasma endothelin levels during myocardial ischemia and reperfusion. Life Sci 1991;48:1745-1749.
22. Maulik N, Liu X, Subramanian R, Das DK: Release of endothelin during reperfusion of ischaemic myocardium. ET-1 release from reperfused heart. Am J Cardiovasc Pathol 1992; 4:133-144.
23. Mair P, Mair J, Bleier J, Waldenberger F, Furtwaengler W, Balogh D, Puschendorf B: Coronary sinus endothelin-1 concentrations after cardioplegic cardiac arrest. Coron Artery Dis 1995;6:533-537.
24. Braunwald E: Unstable angina. A classification. Circulation 1989;80:410-414.
25. Horky K, Jindra A, Peleška J, Jáchymová M, Umnerová J, Šavlíková J, Jarolím M: Plasma concentrations of some cardiovascular humoral factors in essential hypertension and their changes during the treatment with converting enzyme inhibitor lisinopril. Sborn Lek 1993; 94:155-161.
26. Lüscher TF, Oemar BS, Boulanger CM, Hahn AWA: Molecular and cellular biology of endothelin and its receptors. Part I. J Hypertens 1993;11:7-11.
27. Lüscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y: Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993;87(suppl V):V-36-V-44.
28. Hathaway DR, March KL, Lash JA, Adam LP, Wilensky RL: Vascular smooth muscle. A review of the molecular basis of contractility. Circulation 1991;83:382-390.
29. Busse R, Fleming I, Hecker M: Signal transduction in endothelium-dependent vasodilatation. Eur Heart J 1993;14(suppl I):2-9.
30. Fukuda K, Hori S, Kusuhara M, Satoh T, Kyotani S, Handa S, Nakamura Y, Oono H, Yamaguchi K: Effect of endothelin as a coronary vasoconstrictor in the Langendorf-perfused rat heart. Eur J Pharmacol 1989;165:301-304.
31. Hirata K, Matsuda Y, Akita H, Yokoyama M, Fukuzaki H: Myocardial ischemia induced by endothelin in the intact rabbit: Angiographic analysis. Cardiovasc Res 1990;24:879-883.
32. Karwatowska-Prokopczuk E, Wennmalm A: Effects of endothelin on coronary flow, mechanical performance, oxygen uptake, and formation of purines and on outflow of prostacyclin in the isolated rabbit heart. Circ Res 1990; 66:46-54.
33. Clozel JP, Clozel M: Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res 1989;65:1193-1200.
34. Hom GJ, Touhey B, Rubanyi GM: Effects of intracoronary administration of endothelin in anesthetized dogs: Comparison with Bay k 8644 and U 46619. J Cardiovasc Pharmacol 1992;19:194-200.
35. Wang J, Zeballos GA, Kaley G, Hintze TH: Dilatation and constriction of large coronary arteries in conscious dogs by endothelin. Am J Physiol 1991;261:H1379-H1386.
36. Lüscher TF: Endothelin: Key to coronary vasospasm? Circulation 1991;83:701-703.
37. Petersen CL, Hansen A, Frandsen E, Strange S, Jonassen O, Nielsen JR, Digepetersen H, Hesse B: Endothelin release and enhanced regional myocardial ischemia induced by cold-air in patients with stable angina pectoris. Am Heart J 1994;128:511-516.
38. Davies MJ, Thomas AC: Plaque fissuring: The cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363-373.
39. Falk E: Why do plaques rupture? Circulation 1992;86(suppl III):III-30-III-42.
40. Buja LM, Willerson JT: Role of inflammation in coronary plaque disruption. Circulation 1994;89:503-505.
41. Hackett D, Davies D, Chierchia S, Maseri A: Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987;317:1055-1059.
42. Bogaty P, Hackett D, Davies G, Maseri A: Vasoreactivity of the culprit lesion in unstable angina. Circulation 1994;90:5-11.
43. Zeiher AM, Goebel H, Schächinger V, Ihling C: Tissue endothelin-1 immunoreactivity in the active coronary plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995;91: 941-947.